Oxford Respiratory Trials Unit (ORTU)
![]() |
About ORTU
The Oxford Respiratory Trials Unit (ORTU) is a Clinical Trials Unit which specialises in the design, delivery, analysis and administration of trials across the broad scope of Respiratory Medicine and Respiratory Diseases.
We run national and international trials related to our academic areas of interest, as well as supporting trials led by other teams and industry. Our scope of work includes clinical trials at all phases, including translational studies, phase II discovery studies and multicentre definitive randomised trials.
We partner with a broad range of academic funders (National Institute of Health Research, Medical Research Council, British Lung Foundation, National Cancer Research Institute, CRUK) and partners in industry. Key funding for ORTU is derived from the NIHR Research Delivery Network (RDN) and the Oxford NIHR Biomedical Research Centre.
ORTU publications
-
Estimating the disease burden of respiratory syncytial virus (RSV) in older adults in England during the 2023/24 season: a new national hospital-based surveillance system
Preprint
Symes R. et al, (2025)
-
Glucocorticoid treatment and new‐onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: A systematic review and meta‐analysis
Journal article
Golubic R. et al, (2025), Diabetic Medicine, 42
-
ERS Congress 2024: highlights from the Thoracic Oncology Assembly.
Journal article
Pereira Catarata MJ. et al, (2025), ERJ open research, 11, 1171 - 2024
-
Prognostic significance of pleural fluid microbiological positivity in pleural infection: a bicentric 10-year retrospective observational study.
Journal article
Wong C. et al, (2025), Respiratory research, 26
-
Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis Against Multidrug-Resistant Bacteria.
Journal article
Abdulqawi R. et al, (2025), Transplant infectious disease : an official journal of the Transplantation Society
-
Management of Parapneumonic Effusion and Empyema
Journal article
Bhatnagar M. et al, (2025), Clinics in Chest Medicine
-
Long-term outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer.
Journal article
Hassan H. et al, (2025), BMJ Oncol, 4
-
Corrigendum to “No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia” [J Infect 88 (2024) 106161]
Journal article
Wei J. et al, (2024), Journal of Infection, 89, 106361 - 106361